Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paolo Ghia, Gisoo Barnes, Keri Yang, Constantine S. Tam, Tadeusz Robak, Jennifer R. Brown, Brad S. Kahl, Tian Tian, Andy Szeto, Jason C. Paik & Mazyar Shadman. (2023) Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab. Current Medical Research and Opinion 39:11, pages 1505-1511.
Read now
Read now
Constantine S. Tam, Nicole Lamanna, Susan M. O'Brien, Lugui Qiu, Keri Yang, Gisoo Barnes, Ken Wu, Tommi Salmi & Jennifer R. Brown. (2023) Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial. Current Medical Research and Opinion 39:11, pages 1497-1503.
Read now
Read now
Tara Cochrane, Alicia Enrico, David Gomez-Almaguer, Evgueniy Hadjiev, Ewa Lech-Maranda, Tamas Masszi, Eugene Nikitin, Tadeusz Robak, Robert Weinkove, Shang-Ju Wu, Beenish S. Manzoor, Todd Busman, Madhavi Pai, Viktor Komlosi & Mary Ann Anderson. (2023) Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy. Leukemia & Lymphoma 0:0, pages 1-4.
Read now
Read now
Tara Cochrane, Alicia Enrico, David Gomez-Almaguer, Evgueniy Hadjiev, Ewa Lech-Maranda, Tamas Masszi, Eugene Nikitin, Tadeusz Robak, Robert Weinkove, Shang-Ju Wu, Kavita R. Sail, John Pesko, Madhavi Pai, Viktor Komlosi & Mary Ann Anderson. (2022) Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & Lymphoma 63:2, pages 304-314.
Read now
Read now
Articles from other publishers (7)
Pasquale L. Fedele & Stephen Opat. (2024) Chronic Lymphocytic Leukemia—Time to Care for the Survivors. Journal of Clinical Oncology.
Crossref
Crossref
Paolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, Gianluca Gaidano, Elisa Albi, Francesca Romana Mauro, Livio Trentin, Daniele Vallisa, Fabrizio Pane, Antonio Cuneo, Francesco Albano, Giulia Zamprogna, Marta Coscia, Alessandro Gozzetti, Gianluigi Reda, Morena Caira, Paola Finsinger, Giuliana Gualberti, Emilia Iannella, Simona Malgieri & Stefano Molica. (2023) Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. Hematological Oncology 42:1.
Crossref
Crossref
Salem H. Alshemmari, Mustaqeem A. Siddiqui, Ramesh Pandita, Hani Y. Osman, Honar Cherif, Susan O'Brien, Mahmoud Marashi & Khalil Al Farsi. (2023) Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematologica, pages 1-19.
Crossref
Crossref
Rebecca Sheridan, Dorothy McCaughan, Ann Hewison, Eve Roman, Alexandra Smith, Russell Patmore & Debra Howell. (2023) Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers. BMJ Open 13:8, pages e070467.
Crossref
Crossref
Dorothy McCaughan, Eve Roman, Rebecca Sheridan, Ann Hewison, Alexandra G. Smith, Russell Patmore & Debra A. Howell. (2023) Patient perspectives of ‘Watch and Wait’ for chronic haematological cancers: Findings from a qualitative study. European Journal of Oncology Nursing 65, pages 102349.
Crossref
Crossref
Kathleen L. Deering, Murali Sundaram, Qing Harshaw, Jeremiah Trudeau & Jacqueline Claudia Barrientos. (2022) Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study. PLOS ONE 17:10, pages e0270291.
Crossref
Crossref
Kelly M. Trevino, Peter Martin, Zhengming Chen & John P. Leonard. (2022) Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study. Clinical Lymphoma Myeloma and Leukemia 22:2, pages 82-88.
Crossref
Crossref